Haymet Andrew B, Lau Cora, Cho Christina, O'Loughlin Sean, Pinto Nigel V, McGiffin David C, Vallely Michael P, Suen Jacky Y, Fraser John F
Critical Care Research Group, The Prince Charles Hospital, L1 Clinical Sciences Building, Chermside, QLD, 4032, Australia.
Faculty of Medicine, University of Queensland, St Lucia, QLD, Australia.
J Cardiothorac Surg. 2024 Dec 20;19(1):661. doi: 10.1186/s13019-024-03192-x.
Bypass graft surgery is a key surgical intervention for ischemic heart disease (coronary bypass graft surgery) and critical limb ischemia (peripheral bypass graft surgery). Graft occlusion remains a significant clinical problem for both types. Further research into the pathobiological mechanisms of graft occlusion are needed in order to design targeted therapeutic strategies.
Three Large White female pigs (mean weight 52.3 +/- 4.4 kg) received general anaesthesia prior to surgery. The external jugular vein was harvested bilaterally, and a bilateral femoral peripheral arterial bypass was performed, with the superficial femoral artery permanently ligated. The grafts were interrogated immediately post operatively on-table using Medistim MiraQ transit time flowmetry system (Medistim, Oslo, Norway) to assess graft performance. On postoperative day three, the pigs were returned to the operating room, and the grafts were interrogated once again using transit time flowmetry.
Six out of six (100%) successful bilateral EJV to femoral artery bypass grafts were performed. All pigs were successfully recovered, and returned to the operating room at postoperative day 3. The wounds were re-opened and the grafts were inspected. Postoperative graft assessment was performed with transit time flowmetry using the Medistim MiraQTM system (Medistim, Oslo, Norway), demonstrating all grafts were patent (100%).
This model may serve as a platform to gain further mechanistic insight into graft failure pathobiology. By combining a bilateral graft model with gold-standard transit time flowmetry, longitudinal experimentation of targeted therapeutic interventions to combat graft failure may be further studied with improved objectivity.
旁路移植手术是缺血性心脏病(冠状动脉旁路移植手术)和严重肢体缺血(外周旁路移植手术)的关键外科干预措施。移植物闭塞对于这两种手术来说仍然是一个重大的临床问题。需要进一步研究移植物闭塞的病理生物学机制,以便设计有针对性的治疗策略。
三只大白雌性猪(平均体重52.3±4.4千克)在手术前接受全身麻醉。双侧采集颈外静脉,并进行双侧股动脉外周旁路移植手术,将股浅动脉永久性结扎。术后立即在手术台上使用Medistim MiraQ渡越时间血流测量系统(Medistim,挪威奥斯陆)对移植物进行检测,以评估移植物性能。术后第三天,将猪送回手术室,再次使用渡越时间血流测量法对移植物进行检测。
成功完成了六例(100%)双侧颈外静脉至股动脉旁路移植手术。所有猪均成功恢复,并在术后第三天返回手术室。重新打开伤口并检查移植物。使用Medistim MiraQTM系统(Medistim,挪威奥斯陆)通过渡越时间血流测量法进行术后移植物评估,结果显示所有移植物均通畅(100%)。
该模型可作为一个平台,以进一步深入了解移植物失败的病理生物学机制。通过将双侧移植物模型与金标准渡越时间血流测量法相结合,可以更客观地进一步研究针对移植物失败的靶向治疗干预措施的纵向实验。